Validation of a Digital Visual Analogue Scale for Appetite Measurement

General Mills

Status

Completed

Conditions

Healthy

Treatments

Other: Breakfast meal

Study type

Interventional

Funder types

Industry

Identifiers

NCT05287516

2022/03/11

Details and patient eligibility

About

The objective of the study is to validate a newly developed digital visual analog scales with a mobile app for measuring human appetite and compare it with a traditional paper-based visual analog scales for appetite measurement.

Enrollment

130 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Healthy adults 18-70 years.
Body mass index 20-29.9 kg/m² (based on self-reported weight and height).
Understand the study procedures.
Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial.
Willing to follow study procedures on test days.
Willing to abstain from strenuous exercise, consuming alcoholic drinks 24 hours before the test day.
Willing to provide informed consent to participate in the study.

Exclusion criteria

Pregnant or lactating women, or women who are planning to become pregnant during the study
Known food allergies, sensitivity, or intolerance to any food or food ingredients
Participating in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification
Taking medications that affect appetite, metabolism, or blood pressure
Presence of acute diseases or infection
Presence or history of chronic diseases
Diagnosed with eating disorders
Restraint eaters
Lost or gained 5 pounds or more in the past 3 months
On a weight-loss diet, or undergoing intermittent fasting
COVID-19 infection in the past 3 months.